drugset / Press release
NX210c drug candidate peptide strengthens mouse and human blood-brain barriers
2024-09-27 · Axoltis Pharma · original axoltis.com ↗
RESEARCH article Fluids and Barriers of CNS, 2024 – September, 21:76 Chris Greene 1 , Nicolas Rebergue 2 , Gwen Fewell 3 , Damir Janigro 4 , Yann Godfrin 2,5 , Matthew Campbell 1 & Sighild Lemarchant 2 Smurfit Institue of Genetics, Trinity College Dublin, Lincoln Place Gate,Dublin 2, Ireland Axoltis Pharma, 60 Avenue Rockefeller, 69008 Lyon, France. SynVivo, Huntsville, AL 35806, USA Flocell Inc, Cleveland, OH 44103, USA Godfrin Life‐Sciences, 8 Impasse de la Source, 69300 Caluire‐et‐Cuire, France PDF version
The release as fetched from its publisher. axoltis.com ↗